Rexnord Electr. (531888)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth is strong at 23.59%, suggesting product demand and business expansion.
• ROCE of 9.32% is positive, showing some operating-level capital efficiency.
• Book value of ₹60.90 provides a tangible asset base, though price is well above it.
• Price is near the 52-week high, reflecting strong market interest and a potential turnaround narrative.

Concerns

• Net profit growth is -231.65%, and the latest quarter shows a net loss of ₹2 Cr, indicating serious earnings deterioration.
• ROE is only 1.77%, meaning shareholder capital is being deployed with very poor returns.
• At P/E of 38.90 and P/B of 2.19, the valuation is expensive relative to current profitability and book value.
• Piotroski F-Score of 4/9 and zero dividend yield signal weak financial health and no return to shareholders.

AI Analysis

As a value investor, I search for a business I can understand, with an owner's earnings stream and a margin of safety. Rexnord Electr, a ₹177 Cr industrial-products micro-cap, does not yet pass that test. The top line is growing: sales rose 23.59%, and latest quarterly sales are ₹30 Cr. Good. But I buy earnings, not revenue. The latest quarter shows a net loss of ₹2 Cr, and profit growth is -231.65%. A P/E of 38.90 on this fragile base is not a sign of value; it is a hope premium. Book value is ₹60.90, so at ₹133.20 the market is valuing the company at 2.19 times book despite an ROE of only 1.77%. That is not a combination Graham would admire. ROCE at 9.32% barely gives comfort; after tax and working capital demands, the shareholder return is weak. The Piotroski score of 4/9 also tells me the balance sheet and profitability are deteriorating, not healing. There is no dividend, so every rupee of return must come from growth or re-rating. That is speculation unless the company can show durable earnings. The 52-week range of ₹49 to ₹133.20 shows how far the price has run, but price strength should not be confused with business strength. If this is a genuine turnaround, I need proof: rising margins, positive net profit, improving return ratios, and better disclosure. Debt-to-equity and promoter holding are missing, and I cannot underwrite what I cannot see. In Indian small caps, transparency matters. I would rather wait at the sidelines than pay 38 times earnings for a loss-making quarter and hope. Patience, not hope, is the Buffett way.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer